News for Nephros, Inc. (NEPH)

Quarterly Revenue: Achieved $3.9 million, surpassing the estimated $3.57 million, marking a 19% increase from the previous year.Annual Revenue: Recorded $14.2

Nephros Inc (NEPH) is set to release its Q4 2024 earnings on Mar 6, 2025. The consensus estimate for Q4 2024 revenue is $3.57 million, and the earnings are expe

The stock of Haemonetics Corporation (HAE) experienced a notable decline, dropping 5.06% to $59.80 per share. The trading volume reached 1.465 million shares, w

BD (BDX), a leading medical device company, experienced a significant stock movement with a 5.02% drop in its share price, reaching $232.77. The trading volume

American Blood Technologies (HAE) experienced a notable stock decline of 5.20%. The stock is currently priced at $75.81 per share, with a trading volume of 218,

AtriCure (ATRC) experienced a notable stock price increase of 5.04%, reaching $36.44, with a trading volume of 258,045 shares and a turnover rate of 0.53%. The

SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. ( NEPH), a leading water technology company providing filtration solutions to the medical

MHUA (MHUA) experienced a notable stock price increase of 5.53%, reaching $0.557 per share, with a trading volume of 96,731 shares and a turnover rate of 0.37%.

Nephros, Inc. (NASDAQ:NEPH) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsKirin Smith - PCG AdvisoryRobert Banks -...

Net Revenue: $3.5 million, an 8% increase over Q2 2024, but a 6% decline compared to Q3 2023.Net Income: $0.2 million, compared to a net loss of $0.2 million i

Nov 07, 2024 / 09:30PM GMTOperator Good day and welcome to the Nephros Inc third quarter, 2024 financial results conference call. All participants will be in li

Nephros Inc (NEPH) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $3.50 million, and the earnings are expe

Read Investment Analysts’ Downgrades for May 11th (ACH, AMZN, AVYA, BHVN, BKFKF, CARE, CLVS, COIN, CS, CTSH) at ETF Daily News

Read Research Analysts’ Downgrades for April 27th (ACC, APAM, ASBFY, AZUL, BK, BKH, BKRIY, CBRE, COF, CRI) at ETF Daily News

Read Stock Analysts’ Upgrades for April 20th (ABNB, BADFF, BDGI, BKNG, CAR, CHT, CI, CLS, CX, DAL) at ETF Daily News

Read Investment Analysts’ Downgrades for April 19th (A, ADM, ANET, BG, BRKR, CINF, CMS, CTS, EA, ELROF) at ETF Daily News